Benzinga | Nov 5, 2020 05:36PM EST

Regulus Therapeutics Q3 EPS $(0.04) Up From $(0.26) YoY, Sales $5.00M Up From $18.00K YoY

Regulus Therapeutics (NASDAQ:RGLS) reported quarterly losses of $(0.04) per share. This is a 84.62 percent increase over losses of $(0.26) per share from the same period last year. The company reported $5.00 million in sales this quarter. This is a 27.68K percent increase over sales of $18.00 thousand the same period last year.